KKR & Co. finalized a $2.1 billion leveraged loan to fund its latest acquisition.
The debt supports the $5.7 billion purchase of medical-device manufacturer Integer Holdings Corp.
High investor demand enabled KKR to secure a lower interest rate spread.
The firm sold the debt at par, improving on initially discussed terms.
Citigroup led the financing for the all-cash deal announced in August 2026.
The transaction will take Integer private and is scheduled to close by the end of the year.
This move highlights a growing market appetite for acquisition-related leveraged loans.